Rocket Pharmaceuticals
RCKT
#8535
Rank
S$0.35 B
Marketcap
S$3.22
Share price
1.62%
Change (1 day)
-30.61%
Change (1 year)

Earnings for Rocket Pharmaceuticals (RCKT)

Earnings in 2026 (TTM): -S$10.07 Million

According to Rocket Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$0.29 Billion, an increase over its 2024 earnings that were of -S$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rocket Pharmaceuticals from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$10.07 Million-96.48%
2025 -S$0.29 Billion-13.77%
2024 -S$0.34 Billion5.35%
2023 -S$0.32 Billion10.7%
2022 -S$0.29 Billion31.23%
2021 -S$0.22 Billion21.02%
2020 -S$0.18 Billion80.79%
2019 -S$99 Million3.69%
2018 -S$95.48 Million323.4%
2017 -S$22.55 Million-58.93%
2016 -S$54.91 Million-36.96%
2015 -S$87.1 Million613.27%
2014 -S$12.22 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.21 Billion 1,709.44%๐Ÿ‡บ๐Ÿ‡ธ USA